 | • レポートコード：MR2211MG12133 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療機器 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、外科用止血材のグローバル市場規模と予測を記載しています。・外科用止血材のグローバル市場：売上、2017年-2022年、2023年-2028年 ・外科用止血材のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 外科用止血材のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「止血ガーゼ」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 外科用止血材のグローバル主要企業は、Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Productsなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、外科用止血材のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の外科用止血材市場：タイプ別、2017年-2022年、2023年-2028年 世界の外科用止血材市場：タイプ別市場シェア、2021年 ・止血ガーゼ、ゼラチンスポンジ、止血剤 世界の外科用止血材市場：用途別、2017年-2022年、2023年-2028年 世界の外科用止血材市場：用途別市場シェア、2021年 ・病院、診療所、その他 世界の外科用止血材市場：地域・国別、2017年-2022年、2023年-2028年 世界の外科用止血材市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における外科用止血材のグローバル売上、2017年-2022年 ・主要企業における外科用止血材のグローバル売上シェア、2021年 ・主要企業における外科用止血材のグローバル販売量、2017年-2022年 ・主要企業における外科用止血材のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Products ************************************************************* ・調査・分析レポートの概要 外科用止血材市場の定義 市場セグメント 世界の外科用止血材市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の外科用止血材市場規模 世界の外科用止血材市場規模：2021年 VS 2028年 世界の外科用止血材市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの外科用止血材の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の外科用止血材製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：止血ガーゼ、ゼラチンスポンジ、止血剤 外科用止血材のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 外科用止血材の用途別グローバル売上・予測 ・地域別市場分析 地域別外科用止血材市場規模 2021年と2028年 地域別外科用止血材売上・予測 北米市場 - アメリカの外科用止血材市場規模2017年-2028年 - カナダの外科用止血材市場規模2017年-2028年 - メキシコの外科用止血材市場規模2017年-2028年 ヨーロッパ市場 - ドイツの外科用止血材市場規模2017年-2028年 - フランスの外科用止血材市場規模2017年-2028年 - イギリスの外科用止血材市場規模2017年-2028年 - イタリアの外科用止血材市場規模2017年-2028年 - ロシアの外科用止血材市場規模2017年-2028年 アジア市場 - 中国の外科用止血材市場規模2017年-2028年 - 日本の外科用止血材市場規模2017年-2028年 - 韓国の外科用止血材市場規模2017年-2028年 - 東南アジアの外科用止血材市場規模2017年-2028年 - インドの外科用止血材市場規模2017年-2028年 南米市場 - ブラジルの外科用止血材市場規模2017年-2028年 - アルゼンチンの外科用止血材市場規模2017年-2028年 中東・アフリカ市場 - トルコの外科用止血材市場規模2017年-2028年 - イスラエルの外科用止血材市場規模2017年-2028年 - サウジアラビアの外科用止血材市場規模2017年-2028年 - UAEの外科用止血材市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Johnson & Johnson、 BD、 Baxter、 B.Braun、 Cura Medical、 GELITA MEDICAL、 Curasan AG、 Meril Life Sciences、 Zhonghui Shengxi、 Beijing Datsing Bio-tech、 Guizhou Jin Jiu Biotech、 Beijing Taikesiman、 Foryou Medical、 Saikesaisi Holdings Group、 Biotemed、 Hangzhou Singclean Medical Products ... |
Surgical hemostatic material is used to control bleeding intraoperatively.
This report contains market size and forecasts of Surgical Hemostatic Material in global, including the following market information:
Global Surgical Hemostatic Material Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Surgical Hemostatic Material Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Surgical Hemostatic Material companies in 2021 (%)
The global Surgical Hemostatic Material market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemostatic Gauze Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Surgical Hemostatic Material include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Surgical Hemostatic Material manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Surgical Hemostatic Material Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, by Type, 2021 (%)
Hemostatic Gauze
Gelatin Sponge
Styptic Powder
Global Surgical Hemostatic Material Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Surgical Hemostatic Material Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Surgical Hemostatic Material Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Surgical Hemostatic Material revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Surgical Hemostatic Material revenues share in global market, 2021 (%)
Key companies Surgical Hemostatic Material sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Surgical Hemostatic Material sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
1 Introduction to Research & Analysis Reports
1.1 Surgical Hemostatic Material Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Surgical Hemostatic Material Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Surgical Hemostatic Material Overall Market Size
2.1 Global Surgical Hemostatic Material Market Size: 2021 VS 2028
2.2 Global Surgical Hemostatic Material Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Surgical Hemostatic Material Sales: 2017-2028
3 Company Landscape
3.1 Top Surgical Hemostatic Material Players in Global Market
3.2 Top Global Surgical Hemostatic Material Companies Ranked by Revenue
3.3 Global Surgical Hemostatic Material Revenue by Companies
3.4 Global Surgical Hemostatic Material Sales by Companies
3.5 Global Surgical Hemostatic Material Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Surgical Hemostatic Material Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Surgical Hemostatic Material Product Type
3.8 Tier 1, Tier 2 and Tier 3 Surgical Hemostatic Material Players in Global Market
3.8.1 List of Global Tier 1 Surgical Hemostatic Material Companies
3.8.2 List of Global Tier 2 and Tier 3 Surgical Hemostatic Material Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Surgical Hemostatic Material Market Size Markets, 2021 & 2028
4.1.2 Hemostatic Gauze
4.1.3 Gelatin Sponge
4.1.4 Styptic Powder
4.2 By Type – Global Surgical Hemostatic Material Revenue & Forecasts
4.2.1 By Type – Global Surgical Hemostatic Material Revenue, 2017-2022
4.2.2 By Type – Global Surgical Hemostatic Material Revenue, 2023-2028
4.2.3 By Type – Global Surgical Hemostatic Material Revenue Market Share, 2017-2028
4.3 By Type – Global Surgical Hemostatic Material Sales & Forecasts
4.3.1 By Type – Global Surgical Hemostatic Material Sales, 2017-2022
4.3.2 By Type – Global Surgical Hemostatic Material Sales, 2023-2028
4.3.3 By Type – Global Surgical Hemostatic Material Sales Market Share, 2017-2028
4.4 By Type – Global Surgical Hemostatic Material Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Surgical Hemostatic Material Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Surgical Hemostatic Material Revenue & Forecasts
5.2.1 By Application – Global Surgical Hemostatic Material Revenue, 2017-2022
5.2.2 By Application – Global Surgical Hemostatic Material Revenue, 2023-2028
5.2.3 By Application – Global Surgical Hemostatic Material Revenue Market Share, 2017-2028
5.3 By Application – Global Surgical Hemostatic Material Sales & Forecasts
5.3.1 By Application – Global Surgical Hemostatic Material Sales, 2017-2022
5.3.2 By Application – Global Surgical Hemostatic Material Sales, 2023-2028
5.3.3 By Application – Global Surgical Hemostatic Material Sales Market Share, 2017-2028
5.4 By Application – Global Surgical Hemostatic Material Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Surgical Hemostatic Material Market Size, 2021 & 2028
6.2 By Region – Global Surgical Hemostatic Material Revenue & Forecasts
6.2.1 By Region – Global Surgical Hemostatic Material Revenue, 2017-2022
6.2.2 By Region – Global Surgical Hemostatic Material Revenue, 2023-2028
6.2.3 By Region – Global Surgical Hemostatic Material Revenue Market Share, 2017-2028
6.3 By Region – Global Surgical Hemostatic Material Sales & Forecasts
6.3.1 By Region – Global Surgical Hemostatic Material Sales, 2017-2022
6.3.2 By Region – Global Surgical Hemostatic Material Sales, 2023-2028
6.3.3 By Region – Global Surgical Hemostatic Material Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Surgical Hemostatic Material Revenue, 2017-2028
6.4.2 By Country – North America Surgical Hemostatic Material Sales, 2017-2028
6.4.3 US Surgical Hemostatic Material Market Size, 2017-2028
6.4.4 Canada Surgical Hemostatic Material Market Size, 2017-2028
6.4.5 Mexico Surgical Hemostatic Material Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Surgical Hemostatic Material Revenue, 2017-2028
6.5.2 By Country – Europe Surgical Hemostatic Material Sales, 2017-2028
6.5.3 Germany Surgical Hemostatic Material Market Size, 2017-2028
6.5.4 France Surgical Hemostatic Material Market Size, 2017-2028
6.5.5 U.K. Surgical Hemostatic Material Market Size, 2017-2028
6.5.6 Italy Surgical Hemostatic Material Market Size, 2017-2028
6.5.7 Russia Surgical Hemostatic Material Market Size, 2017-2028
6.5.8 Nordic Countries Surgical Hemostatic Material Market Size, 2017-2028
6.5.9 Benelux Surgical Hemostatic Material Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Surgical Hemostatic Material Revenue, 2017-2028
6.6.2 By Region – Asia Surgical Hemostatic Material Sales, 2017-2028
6.6.3 China Surgical Hemostatic Material Market Size, 2017-2028
6.6.4 Japan Surgical Hemostatic Material Market Size, 2017-2028
6.6.5 South Korea Surgical Hemostatic Material Market Size, 2017-2028
6.6.6 Southeast Asia Surgical Hemostatic Material Market Size, 2017-2028
6.6.7 India Surgical Hemostatic Material Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Surgical Hemostatic Material Revenue, 2017-2028
6.7.2 By Country – South America Surgical Hemostatic Material Sales, 2017-2028
6.7.3 Brazil Surgical Hemostatic Material Market Size, 2017-2028
6.7.4 Argentina Surgical Hemostatic Material Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Surgical Hemostatic Material Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Surgical Hemostatic Material Sales, 2017-2028
6.8.3 Turkey Surgical Hemostatic Material Market Size, 2017-2028
6.8.4 Israel Surgical Hemostatic Material Market Size, 2017-2028
6.8.5 Saudi Arabia Surgical Hemostatic Material Market Size, 2017-2028
6.8.6 UAE Surgical Hemostatic Material Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Surgical Hemostatic Material Major Product Offerings
7.1.4 Johnson & Johnson Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 BD
7.2.1 BD Corporate Summary
7.2.2 BD Business Overview
7.2.3 BD Surgical Hemostatic Material Major Product Offerings
7.2.4 BD Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.2.5 BD Key News
7.3 Baxter
7.3.1 Baxter Corporate Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Surgical Hemostatic Material Major Product Offerings
7.3.4 Baxter Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.3.5 Baxter Key News
7.4 B.Braun
7.4.1 B.Braun Corporate Summary
7.4.2 B.Braun Business Overview
7.4.3 B.Braun Surgical Hemostatic Material Major Product Offerings
7.4.4 B.Braun Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.4.5 B.Braun Key News
7.5 Cura Medical
7.5.1 Cura Medical Corporate Summary
7.5.2 Cura Medical Business Overview
7.5.3 Cura Medical Surgical Hemostatic Material Major Product Offerings
7.5.4 Cura Medical Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.5.5 Cura Medical Key News
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Corporate Summary
7.6.2 GELITA MEDICAL Business Overview
7.6.3 GELITA MEDICAL Surgical Hemostatic Material Major Product Offerings
7.6.4 GELITA MEDICAL Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.6.5 GELITA MEDICAL Key News
7.7 Curasan AG
7.7.1 Curasan AG Corporate Summary
7.7.2 Curasan AG Business Overview
7.7.3 Curasan AG Surgical Hemostatic Material Major Product Offerings
7.7.4 Curasan AG Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.7.5 Curasan AG Key News
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Corporate Summary
7.8.2 Meril Life Sciences Business Overview
7.8.3 Meril Life Sciences Surgical Hemostatic Material Major Product Offerings
7.8.4 Meril Life Sciences Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.8.5 Meril Life Sciences Key News
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Corporate Summary
7.9.2 Zhonghui Shengxi Business Overview
7.9.3 Zhonghui Shengxi Surgical Hemostatic Material Major Product Offerings
7.9.4 Zhonghui Shengxi Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.9.5 Zhonghui Shengxi Key News
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Corporate Summary
7.10.2 Beijing Datsing Bio-tech Business Overview
7.10.3 Beijing Datsing Bio-tech Surgical Hemostatic Material Major Product Offerings
7.10.4 Beijing Datsing Bio-tech Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.10.5 Beijing Datsing Bio-tech Key News
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Corporate Summary
7.11.2 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Business Overview
7.11.3 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Major Product Offerings
7.11.4 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.11.5 Guizhou Jin Jiu Biotech Key News
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Corporate Summary
7.12.2 Beijing Taikesiman Surgical Hemostatic Material Business Overview
7.12.3 Beijing Taikesiman Surgical Hemostatic Material Major Product Offerings
7.12.4 Beijing Taikesiman Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.12.5 Beijing Taikesiman Key News
7.13 Foryou Medical
7.13.1 Foryou Medical Corporate Summary
7.13.2 Foryou Medical Surgical Hemostatic Material Business Overview
7.13.3 Foryou Medical Surgical Hemostatic Material Major Product Offerings
7.13.4 Foryou Medical Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.13.5 Foryou Medical Key News
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Corporate Summary
7.14.2 Saikesaisi Holdings Group Business Overview
7.14.3 Saikesaisi Holdings Group Surgical Hemostatic Material Major Product Offerings
7.14.4 Saikesaisi Holdings Group Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.14.5 Saikesaisi Holdings Group Key News
7.15 Biotemed
7.15.1 Biotemed Corporate Summary
7.15.2 Biotemed Business Overview
7.15.3 Biotemed Surgical Hemostatic Material Major Product Offerings
7.15.4 Biotemed Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.15.5 Biotemed Key News
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Corporate Summary
7.16.2 Hangzhou Singclean Medical Products Business Overview
7.16.3 Hangzhou Singclean Medical Products Surgical Hemostatic Material Major Product Offerings
7.16.4 Hangzhou Singclean Medical Products Surgical Hemostatic Material Sales and Revenue in Global (2017-2022)
7.16.5 Hangzhou Singclean Medical Products Key News
8 Global Surgical Hemostatic Material Production Capacity, Analysis
8.1 Global Surgical Hemostatic Material Production Capacity, 2017-2028
8.2 Surgical Hemostatic Material Production Capacity of Key Manufacturers in Global Market
8.3 Global Surgical Hemostatic Material Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Surgical Hemostatic Material Supply Chain Analysis
10.1 Surgical Hemostatic Material Industry Value Chain
10.2 Surgical Hemostatic Material Upstream Market
10.3 Surgical Hemostatic Material Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Surgical Hemostatic Material Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer